Question
Anti Helicobacter Pylori Drugs
Answer
H. pylori eradication requires combination therapy to reduce the resistance-emergence risk monotherapy would carry against this organism.
Standard triple therapy: a proton pump inhibitor + two antibiotics (typically Clarithromycin and Amoxicillin, or Metronidazole in penicillin-allergic patients), given for 10-14 days — the PPI creates a less hostile environment for the antibiotics to work while directly promoting ulcer healing.
Bismuth-based quadruple therapy: Bismuth subsalicylate, Metronidazole, Tetracycline, plus a PPI — used where clarithromycin resistance is prevalent or triple therapy has failed; bismuth itself has direct antibacterial action against H. pylori plus a mucosal-coating protective effect.
Rationale: dual antibiotic coverage specifically reduces resistance-emergence risk that monotherapy would carry against a single bacterial species, the same combination-therapy logic applied throughout antimicrobial therapy.

